These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 22836801)
1. Plexiform neurofibroma of the eye region occurring in patients without neurofibromatosis type 1. Bechtold D; Hove HD; Prause JU; Heegaard S; Toft PB Ophthalmic Plast Reconstr Surg; 2012; 28(6):413-5. PubMed ID: 22836801 [TBL] [Abstract][Full Text] [Related]
2. Visual outcomes in children with neurofibromatosis type 1 and orbitotemporal plexiform neurofibromas. Avery RA; Dombi E; Hutcheson KA; Acosta MT; Baldwin AM; Madigan WP; Gillespie A; Fitzgibbon EJ; Packer RJ; Widemann BC Am J Ophthalmol; 2013 Jun; 155(6):1089-1094.e1. PubMed ID: 23453281 [TBL] [Abstract][Full Text] [Related]
3. Dysplasia of the orbit and adjacent bone associated with plexiform neurofibroma and ocular disease in 42 NF-1 patients. Friedrich RE; Stelljes C; Hagel C; Giese M; Scheuer HA Anticancer Res; 2010 May; 30(5):1751-64. PubMed ID: 20592374 [TBL] [Abstract][Full Text] [Related]
4. [Isolated late-onset plexiform neurofibroma in the absence of neurofibromatosis]. Levy Bencheton A; Mallet S; Rojat Habib MC; Figarella-Branger D; Sigaudy S; Grob JJ; Richard MA Ann Dermatol Venereol; 2010 Apr; 137(4):301-4. PubMed ID: 20417366 [TBL] [Abstract][Full Text] [Related]
5. The primacy of NF1 loss as the driver of tumorigenesis in neurofibromatosis type 1-associated plexiform neurofibromas. Pemov A; Li H; Patidar R; Hansen NF; Sindiri S; Hartley SW; Wei JS; Elkahloun A; Chandrasekharappa SC; ; Boland JF; Bass S; ; Mullikin JC; Khan J; Widemann BC; Wallace MR; Stewart DR Oncogene; 2017 Jun; 36(22):3168-3177. PubMed ID: 28068329 [TBL] [Abstract][Full Text] [Related]
6. [Plexiform cervical neurofibroma: about a case]. Bouimetarhan L; Bellamlih H; En-Nafaa I; Fenni JE; Amil T; Radouane B Pan Afr Med J; 2018; 30():41. PubMed ID: 30167068 [TBL] [Abstract][Full Text] [Related]
7. Is a plexiform neurofibroma pathognomonic of neurofibromatosis type I? Lin V; Daniel S; Forte V Laryngoscope; 2004 Aug; 114(8):1410-4. PubMed ID: 15280718 [TBL] [Abstract][Full Text] [Related]
8. Mosaic Neurofibromatosis Type 1 With Multiple Cutaneous Diffuse and Plexiform Neurofibromas of the Lower Leg. Friedrich RE; Hagel C; Kohlrusch FK; Schanze I; Wieland I; Zenker M Anticancer Res; 2020 Jun; 40(6):3423-3427. PubMed ID: 32487640 [TBL] [Abstract][Full Text] [Related]
9. A novel diagnostic method to detect truncated neurofibromin in neurofibromatosis 1. Esposito T; Piluso G; Saracino D; Uccello R; Schettino C; Dato C; Capaldo G; Giugliano T; Varriale B; Paolisso G; Di Iorio G; Melone MA J Neurochem; 2015 Dec; 135(6):1123-8. PubMed ID: 26478990 [TBL] [Abstract][Full Text] [Related]
10. Plexiform Neurofibroma With Activating KRAS Mutation and Segmental Presentation Involving the Unilateral Eyelid. Stallworth JY; Smith LD; Vagefi MR; Pekmezci M Ophthalmic Plast Reconstr Surg; 2022 Jul-Aug 01; 38(4):e104-e106. PubMed ID: 35797671 [TBL] [Abstract][Full Text] [Related]
12. [Unilateral facial and cerebral hyperplasia associated with neurofibromatosis type 1. Report of four patients]. Pascual-Castroviejo I; Pascual-Pascual SI; Burgueno M; Martin-Perez M; Palencia R; Garcia-Segura JM; Valero C Rev Neurol; 2006 Sep 16-30; 43(6):346-52. PubMed ID: 16981165 [TBL] [Abstract][Full Text] [Related]
13. A clinical and genetic overview of 18 years neurofibromatosis type 1 molecular diagnostics in the Netherlands. van Minkelen R; van Bever Y; Kromosoeto JN; Withagen-Hermans CJ; Nieuwlaat A; Halley DJ; van den Ouweland AM Clin Genet; 2014 Apr; 85(4):318-27. PubMed ID: 23656349 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic delay of NF1 in hemifacial hypertrophy due to plexiform neurofibromas. Overdiek A; Feifel H; Schaper J; Mayatepek E; Rosenbaum T Brain Dev; 2006 Jun; 28(5):275-80. PubMed ID: 16481142 [TBL] [Abstract][Full Text] [Related]
15. Allelic loss of the NF1 gene in NF1-associated plexiform neurofibromas. Kluwe L; Friedrich RE; Mautner VF Cancer Genet Cytogenet; 1999 Aug; 113(1):65-9. PubMed ID: 10459349 [TBL] [Abstract][Full Text] [Related]
16. Characteristics of children enrolled in treatment trials for NF1-related plexiform neurofibromas. Kim A; Gillespie A; Dombi E; Goodwin A; Goodspeed W; Fox E; Balis FM; Widemann BC Neurology; 2009 Oct; 73(16):1273-9. PubMed ID: 19841379 [TBL] [Abstract][Full Text] [Related]
17. Lisch nodule asymmetry in a patient with neurofibromatosis type 1. Nichol JC; Amato JE; Chung SM J Pediatr Ophthalmol Strabismus; 2003; 40(4):243-4. PubMed ID: 12908541 [No Abstract] [Full Text] [Related]
18. Orbit deformities in craniofacial neurofibromatosis type 1. Jacquemin C; Bosley TM; Svedberg H AJNR Am J Neuroradiol; 2003 Sep; 24(8):1678-82. PubMed ID: 13679291 [TBL] [Abstract][Full Text] [Related]
19. NF1 deletions in S-100 protein-positive and negative cells of sporadic and neurofibromatosis 1 (NF1)-associated plexiform neurofibromas and malignant peripheral nerve sheath tumors. Perry A; Roth KA; Banerjee R; Fuller CE; Gutmann DH Am J Pathol; 2001 Jul; 159(1):57-61. PubMed ID: 11438454 [TBL] [Abstract][Full Text] [Related]
20. Oral manifestations of neurofibromatosis type 1 in children with facial plexiform neurofibroma: report of three cases. Cunha KS; Rozza-de-Menezes RE; Andrade RM; Almeida L; Janini M; Geller M J Clin Pediatr Dent; 2015; 39(2):168-71. PubMed ID: 25823487 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]